Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer
Ramos S, Kulkarni A, Oliver M, Danilack V, Mathews C. Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer. International Journal Of Gynecological Cancer 2022, 33: 57-65. PMID: 36423959, DOI: 10.1136/ijgc-2022-003603.Peer-Reviewed Original ResearchMeSH KeywordsChemotherapy, AdjuvantFemaleFrailtyHumansOvarian NeoplasmsPostoperative ComplicationsRetrospective StudiesRisk FactorsConceptsInitiation of chemotherapyHigh-frailty groupModified Frailty IndexFrailty groupOvarian cancerFrailty scoreMFI scoreHigher mFI scoresPatients 18 yearsRetrospective cohort studyHigh-risk patientsTertiary medical centerElectronic medical recordsAdjuvant chemotherapyChemotherapy initiationFrail groupNeoadjuvant chemotherapyCohort studyOverall survivalFrailty indexPreoperative counselingModerate frailtyFunctional statusMedical recordsMedical Center